AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. LTT Bio-Pharma Co., Ltd.
  3. Financials
  4. Earnings per share

LTT Bio-Pharma Co., Ltd.【JP:E00982】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 20258,225.7+262.28%
Mar 31, 20242,270.5+326.18%
Mar 31, 2023532.8-126.66%
Mar 31, 2022-1,998.2-245.26%
Mar 31, 20211,375.6-122.47%
Mar 31, 2020-6,121.3-346.75%
Mar 31, 20192,480.7-70.95%
Mar 31, 20188,539.6-20.03%
Mar 31, 201710,678.5+432.59%
Mar 31, 20162,005-83.30%
Mar 31, 201512,006.6+1417.04%
Mar 31, 2014791.5-10.22%
Mar 31, 2013881.6-275.17%
Mar 31, 2012-503.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)